Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1545

1.

Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma.

Mariette C, Taillier G, Van Seuningen I, Triboulet JP.

Ann Thorac Surg. 2004 Oct;78(4):1177-83. Review.

PMID:
15464466
2.

En bloc esophagectomy reduces local recurrence and improves survival compared with transhiatal resection after neoadjuvant therapy for esophageal adenocarcinoma.

Rizzetto C, DeMeester SR, Hagen JA, Peyre CG, Lipham JC, DeMeester TR.

J Thorac Cardiovasc Surg. 2008 Jun;135(6):1228-36. doi: 10.1016/j.jtcvs.2007.10.082. Epub 2008 May 23.

3.

Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.

Pennathur A, Luketich JD, Landreneau RJ, Ward J, Christie NA, Gibson MK, Schuchert M, Cooper K, Land SR, Belani CP.

Ann Thorac Surg. 2008 Jun;85(6):1930-6; discussion 1936-7. doi: 10.1016/j.athoracsur.2008.01.097.

PMID:
18498797
4.

Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.

Liao Z, Zhang Z, Jin J, Ajani JA, Swisher SG, Stevens CW, Ho L, Smythe R, Vaporciyan AA, Putnam JB Jr, Walsh GL, Roth JA, Yao JC, Allen PK, Cox JD, Komaki R.

Int J Radiat Oncol Biol Phys. 2004 Dec 1;60(5):1484-93.

PMID:
15590179
5.

Neoadjuvant chemoradiation therapy in patients with surgically treated esophageal cancer.

Vermund H, Pories WJ, Hillard J, Wiley AL, Youngblood R.

Acta Oncol. 2001;40(5):558-65. Review.

PMID:
11669326
6.

Mature survival results with preoperative cisplatin, protracted infusion 5-fluorouracil, and 44-Gy radiotherapy for esophageal cancer.

Kleinberg L, Knisely JP, Heitmiller R, Zahurak M, Salem R, Burtness B, Heath EI, Forastiere AA.

Int J Radiat Oncol Biol Phys. 2003 Jun 1;56(2):328-34.

PMID:
12738305
7.

[Preoperative chemoradiation in esophageal cancer: experience of a single center in 102 patients].

Imdahl A, Schöffel U, Ruf G, Hopf UT.

Zentralbl Chir. 2004 Oct;129(5):350-5. German.

PMID:
15486784
8.

Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.

Jin J, Liao Z, Zhang Z, Ajani J, Swisher S, Chang JY, Jeter M, Guerrero T, Stevens CW, Vaporciyan A, Putnam J Jr, Walsh G, Smythe R, Roth J, Yao J, Allen P, Cox JD, Komaki R.

Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):427-36.

PMID:
15380576
9.

[Changes and complication rate in surgery for thoracic esophageal carcinoma].

Meyer T, Merkel S, Göhl J, Stumpf P, Hohenberger W.

Zentralbl Chir. 2003 Aug;128(8):631-9. German.

PMID:
12931257
10.

Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.

Lee PC, Port JL, Paul S, Stiles BM, Altorki NK.

Ann Thorac Surg. 2009 Jul;88(1):186-92; discussion 192-3. doi: 10.1016/j.athoracsur.2009.03.079.

PMID:
19559222
11.

Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer.

Kelsen DP, Winter KA, Gunderson LL, Mortimer J, Estes NC, Haller DG, Ajani JA, Kocha W, Minsky BD, Roth JA, Willett CG; Radiation Therapy Oncology Group; USA Intergroup.

J Clin Oncol. 2007 Aug 20;25(24):3719-25.

PMID:
17704421
12.

Squamous cell carcinoma of the esophagus infiltrating the respiratory tract is less sensitive to preoperative concurrent radiation and chemotherapy.

Yano M, Shiozaki H, Tsujinaka T, Inoue M, Doki Y, Fujiwara Y, Monden M.

J Am Coll Surg. 2000 Dec;191(6):626-34.

PMID:
11129811
13.

Selection of operation for esophageal cancer based on staging.

Skinner DB, Little AG, Ferguson MK, Soriano A, Staszak VM.

Ann Surg. 1986 Oct;204(4):391-401.

14.

Impact of preoperative radiochemotherapy on postoperative course and survival in patients with locally advanced squamous cell oesophageal carcinoma.

Mariette C, Piessen G, Lamblin A, Mirabel X, Adenis A, Triboulet JP.

Br J Surg. 2006 Sep;93(9):1077-83.

PMID:
16779882
15.

Preoperative chemoradiotherapy prior to esophagectomy in elderly patients is not associated with increased morbidity.

Rice DC, Correa AM, Vaporciyan AA, Sodhi N, Smythe WR, Swisher SG, Walsh GL, Putnam JB Jr, Komaki R, Ajani JA, Roth JA.

Ann Thorac Surg. 2005 Feb;79(2):391-7; discussionn 391-7.

PMID:
15680801
16.

Neoadjuvant chemoradiation versus chemotherapy for patients undergoing esophagectomy for esophageal cancer.

Luu TD, Gaur P, Force SD, Staley CA, Mansour KA, Miller JI Jr, Miller DL.

Ann Thorac Surg. 2008 Apr;85(4):1217-23; discussion 1223-4. doi: 10.1016/j.athoracsur.2007.11.070.

PMID:
18355499
17.

A three-step strategy of induction chemotherapy then chemoradiation followed by surgery in patients with potentially resectable carcinoma of the esophagus or gastroesophageal junction.

Ajani JA, Komaki R, Putnam JB, Walsh G, Nesbitt J, Pisters PW, Lynch PM, Vaporciyan A, Smythe R, Lahoti S, Raijman I, Swisher S, Martin FD, Roth JA.

Cancer. 2001 Jul 15;92(2):279-86.

PMID:
11466680
19.

Local recurrence after total or subtotal esophagectomy for esophageal cancer.

Blewett CJ, Miller JD, Ramlawi B, Young JE, BennettWF, Urschel JD.

J Exp Clin Cancer Res. 2001 Mar;20(1):17-9.

PMID:
11370823
20.

Survival after esophageal resection for carcinoma: the importance of the histologic cell type.

Alexiou C, Khan OA, Black E, Field ML, Onyeaka P, Beggs L, Duffy JP, Beggs DF.

Ann Thorac Surg. 2006 Sep;82(3):1073-7.

PMID:
16928541

Supplemental Content

Support Center